← Back to headlines
Axsome Therapeutics Stock Rises 16% YTD, Analysts See Further Growth
Axsome Therapeutics stock has seen a 16% increase year-to-date, with Wall Street analysts suggesting it has further potential for growth.
23 Aug, 21:20 — 23 Aug, 21:20
Sources
Showing 1 of 1 sources
